Concourse Financial Group Securities, Inc. Exicure, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share
Q2 2024 Jul 23, 2024	BUY	$0.3 - $0.64 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.53 - $0.84 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.37 - $0.75 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.71 - $1.36 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.71 - $1.36 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.85 - $1.44 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.78 - $1.58 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.71 - $9.3 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.53 - $8.5 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$2.16 - $6.36 $0 - $0

Others Institutions Holding XCUR

# of Institutions

Shares Held

287K

Call Options Held

Put Options Held

View Full List

About EXICURE, INC.

Ticker XCUR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,962,580
Market Cap $55.5M
Description
Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic and chronic pain. The company has a collaboration, option, and license agreement with AbbVie...

More about XCUR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account